Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. (BDTX) is a publicly traded company in the Unknown sector. Across all available filings, 27 corporate insiders have executed 530 transactions totaling $134.6M, demonstrating a bullish sentiment with $76.4M in net insider flow. The most recent transaction on Jan 21, 2026 involved a transaction of 600,000 shares valued at $0.
BDTX Insider Activity Summary
Who Is Buying BDTX Stock?
No significant insider buying has been recorded for BDTX in the recent period.
Who Is Selling BDTX Stock?
No significant insider selling has been recorded for BDTX in the recent period.
Is Black Diamond Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for BDTX is bullish with an Insider Alignment Score of 78/100 and a net flow of $76.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
BDTX Frequently Asked Questions
Understanding BDTX Insider Activity
Insider trading at Black Diamond Therapeutics, Inc. (BDTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 27 insiders are actively trading BDTX stock, having executed 530 transactions in the past 90 days. The most active insider is Bradley J. Bolzon Phd (Executive), who has made 182 transactions totaling $28.7M.
Related Tools
Track Black Diamond Therapeutics, Inc. Insider Activity
Get notified when executives and directors at BDTX file new Form 4 transactions